These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 15114410)
1. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide. Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410 [TBL] [Abstract][Full Text] [Related]
2. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat. Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470 [TBL] [Abstract][Full Text] [Related]
3. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats. Li C; Li X; Choi JS Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886 [TBL] [Abstract][Full Text] [Related]
4. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Li X; Choi JS Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395 [TBL] [Abstract][Full Text] [Related]
5. Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance. Lum BL; Kaubisch S; Fisher GA; Brown BW; Sikic BI Cancer Chemother Pharmacol; 2000; 45(4):305-11. PubMed ID: 10755319 [TBL] [Abstract][Full Text] [Related]
6. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues. Tanaka C; Kawai R; Rowland M Drug Metab Dispos; 2000 May; 28(5):582-9. PubMed ID: 10772639 [TBL] [Abstract][Full Text] [Related]
7. Microdialysis assessment of microfibrous collagen containing a P-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etoposide. Sato H; Kitazawa H; Adachi I; Horikoshi I Pharm Res; 1996 Oct; 13(10):1565-9. PubMed ID: 8899852 [TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine. Dorababu M; Nishimura A; Prabha T; Naruhashi K; Sugioka N; Takada K; Shibata N Biomed Pharmacother; 2009 Nov; 63(9):697-702. PubMed ID: 19819100 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue distribution of liposomal etoposide in rats. Sistla A; Smith DJ; Kobrinsky NL; Kumar K Drug Deliv; 2009 Nov; 16(8):423-9. PubMed ID: 19839786 [TBL] [Abstract][Full Text] [Related]
10. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats. Molpeceres J; Chacón M; Aberturas MR; Guzmán M; Díez ML; Rodriguez-Puyol M Pharmazie; 2001 Jan; 56(1):78-82. PubMed ID: 11210676 [TBL] [Abstract][Full Text] [Related]
11. Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution. Burgio DE; Gosland MP; McNamara aPJ J Pharmacol Exp Ther; 1998 Dec; 287(3):911-7. PubMed ID: 9864272 [TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding. Hedaya MA; Daoud SS Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282 [TBL] [Abstract][Full Text] [Related]
14. Effects of morin on the pharmacokinetics of etoposide in rats. Li X; Yun JK; Choi JS Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145 [TBL] [Abstract][Full Text] [Related]
15. Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A. Jin M; Shimada T; Yokogawa K; Nomura M; Mizuhara Y; Furukawa H; Ishizaki J; Miyamoto K Int J Pharm; 2005 Apr; 293(1-2):137-44. PubMed ID: 15778051 [TBL] [Abstract][Full Text] [Related]
16. Effects of cyclosporine A on the hepatobiliary disposition and hepatic uptake of etoposide in an isolated perfused rat liver model. Khezrian M; Sheikholeslami B; Dadashzadeh S; Lavasani H; Rouini M Cancer Chemother Pharmacol; 2015 May; 75(5):961-8. PubMed ID: 25757960 [TBL] [Abstract][Full Text] [Related]
17. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats. Saad SY; Najjar TA Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B. Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy. Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445 [TBL] [Abstract][Full Text] [Related]
20. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance. Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]